| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Anne Borgman | Director | Jun 20, 2024 | |||
| John G. Houston | Director | Jun 20, 2024 | |||
| Sourav Kundu | Sr VP, Dev. & Mfg. | Mar 29, 2024 | |||
| Han Myint | Chief Medical Officer | Mar 29, 2024 | |||
| Steven P. Cobourn | Chief Financial Officer | Mar 29, 2024 | |||
| Timothy Mayer | Chief Operating Officer | Mar 29, 2024 | |||
| Linda Liu | SVP, Research | Jan 31, 2022 | |||
| Kabakoff David S | Director | Jun 20, 2024 | |||
| Elaine V. Jones | Director | Jun 20, 2024 | |||
| Ellen Feigal | Director | Jun 20, 2024 | |||
| Michael Richman | President & CEO, Director | Mar 29, 2024 | |||
| Stella Xu | Director | Jun 24, 2021 | |||
| Garry A. Nicholson | Director | Jun 22, 2023 | |||
| Kevin G. Shaw | Sr VP, General Counsel | Mar 29, 2024 | |||
| Sol Langermann | Chief Scientific Officer | Mar 29, 2024 | |||
| Stephen W. Webster | Director | Jun 20, 2024 | |||
| Chau Q. Khuong | Director | Jun 22, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|